EXCERPT:
MAKARY: “Now, the CDC has tried to quickly downplay it and said, 'Oh, well, we checked it out in other databases like the Medicare database,' which is a database of billing codes, it's not designed to look at actually clinical events. So it's not fair to say that we looked at another imprecise database and didn't see it there. And it's not that far of a stretch -- if you remember, in September we had a big study come out that showed that the incidence of complications, severe adverse events, not just lying in bed, was 1 in 800 and the German study said it was 1 in 5,000. Now I am not saying pull the vaccine from the market, but we've pulled vaccines for frequencies of adverse events far less common than we're seeing with the Covid vaccine. Rotavirus was pulled for a complication rate of 1 in 10,000, and the swine flu vaccine was pulled for a complication rate of 1 in 100,000. So, there is clearly something there. The FDA’s own analysis that somebody there co-authored with other researchers found that there was a clear incidence of pulmonary embolism, 50% higher than baseline from the Covid vaccine. It's not a big stretch. Now, the FDA, which is supposed to be our top regulatory agency, said, 'Don’t release this data to the public because it will hurt public trust.' The way to increase public trust is to be totally honest and transparent. And show us the underlying dataset. Instead, the CDC has said, 'Look, we ran other statistical tests, and in the other statistical tests we didn’t see the complication play out.' But you don’t just run statistical test after test until one of them shows that the signal goes away. You actually run the proper statistical tests, which is why the underlying dataset should be public information."